Keyword
in
Collection
Date
to
Download Folder

0 items

Houston Voice, No. 1003, January 14, 2000
File 013
Citation
MLA
APA
Chicago/Turabian
Houston Voice, No. 1003, January 14, 2000 - File 013. 2000-01-14. University of Houston Libraries. University of Houston Digital Library. Web. December 16, 2017. http://digital.lib.uh.edu/collection/montrose/item/7109/show/7088.

Disclaimer: This is a general citation for reference purposes. Please consult the most recent edition of your style manual for the proper formatting of the type of source you are citing. If the date given in the citation does not match the date on the digital item, use the more accurate date below the digital item.

(2000-01-14). Houston Voice, No. 1003, January 14, 2000 - File 013. Montrose Voice. University of Houston Libraries. Retrieved from http://digital.lib.uh.edu/collection/montrose/item/7109/show/7088

Disclaimer: This is a general citation for reference purposes. Please consult the most recent edition of your style manual for the proper formatting of the type of source you are citing. If the date given in the citation does not match the date on the digital item, use the more accurate date below the digital item.

Houston Voice, No. 1003, January 14, 2000 - File 013, 2000-01-14, Montrose Voice, University of Houston Libraries, accessed December 16, 2017, http://digital.lib.uh.edu/collection/montrose/item/7109/show/7088.

Disclaimer: This is a general citation for reference purposes. Please consult the most recent edition of your style manual for the proper formatting of the type of source you are citing. If the date given in the citation does not match the date on the digital item, use the more accurate date below the digital item.

URL
Embed Image
Compound Item Description
Title Houston Voice, No. 1003, January 14, 2000
Contributor
  • Hennie, Matthew A.
Publisher Window Media
Date January 14, 2000
Language English
Subject
  • LGBTQ community
  • LGBTQ people
  • Gay liberation movement
Place
  • Houston, Texas
Genre
  • newspapers
Type
  • Text
Identifier OCLC: 31485329
Rights In Copyright: This item is protected by copyright. Copyright to this resource is held by the creator or current rights holder, and the resource is provided here for educational purposes. It may not be reproduced or distributed in any format without permission of the copyright owner. Users assume full responsibility for any infringement of copyright or related rights.
Note This item was digitized from materials loaned by the Gulf Coast Archive and Museum (GCAM).
Item Description
Title File 013
Transcript 12 NEWS JANUARY 14, 2000 • HOUSTON VOICE Youth takes on school officials to form student-led gay group >■ Continued from Page 1 "I guess you could say I'm an 'in your face' kind of guy," he says during an interview last week at LSU in Baton Rouge, where he takes several hours of classes after leaving McKinley High School "But hey, I'm gay, I'm queer, I'm out, I'm proud— have I missed anything?" He grins broadly. "Could you tell?" Could it be by the rainbow rings he wears around his neck7 Or the rainbow tag pinned to a shoulder strap on his backpack? Or the rainbow flag on the back of his mom's car? Perhaps another telltale sign is the way he eagerly whips out his wallet and pulls out two photographs of his boyfriend, who attends another Baton Rouge high school. For a moment, Pfeiffer's face clouds. "He has a hard time sometimes," he said of his boyfriend. "He's taunted and teased at school, but he says it's okay, that it's become 'normal' VIRAMUNE (nevirapine) Tablets VIRAMUNE (nevirapine) Oral Suspension for him. That's disgusting. I wish 1 could do more to help him." "Do more" doesn't adequately describe what Marty Pfeiffer is doing—for himself, his boyfriend, and countless other gay teens in Baton Rouge. Pfeiffer has taken on the East Baton Rouge-Parish School Board, McKinley High where he wants to start a Gay-Straight Alliance for gay and gay-supportive students, and homo- phobes who have unsuccessfully tried to skewer him and his sexual orientation on radio programs—all at great risk for being so public at a time when fanatics think nothing of sending hate mail, or worse. "Yes, there are consequences for my actions and for being so out, but the benefits far outweigh any negative consequences," Pfeiffer said. "People have to know it's okay to be gay, to be out, to be themselves, and they don't have to take the Table 1 wnuWLns Die muted laboratory abnormalities occurring in pediatric patents <" Trial Bl B82 and m Wow-up rnaiBi892 Tape I Number ol PerJatnc Patents (%) wit) Matted Laboratory Abnonrames «i Tnas Bl 882 and Bl 89? Combined St'/ERE ANU LIFE IHflfA'tNING 5KIN RiAC'IONS STEVENS jOHN'SUN iYNiJHGMf TOXIC EPIDERMAL NECROLYSIS! INCLIJOING FATAL CASES HAVE OCCURRED IN PATIENTS TREATED WITH VIHAMUW~ (Sec WARNINGS) SEVERE AND LIFE THREATENING HEPATOTOXkCITY INCLUDING FATAL HEPATIC NECROSIS HAS OCCURRED JH PATIENTS TREATED WITH VIRAMUNE- .See WARNINGS. RESISTANT VIRUS EMERGES RAPIDLY AM UWEORMLY WHEN VIRAMUNE- IS ADMINISTERED AS MONOTHERAPY THEREFORE. VIRAMUNE" SHOULD ALWAYS BE ADMINISTERED IN COMBINATION WITH ANTIRETROVIRAL AGENTS No (%) ol Pahents n*37 Hematology Decreased Hg (<8.0 n/dL) ? (19| Decreased platelets (<SO.00O/mm') 4 (11) Decreased neutiophus f<7S0/mm') 14 (38) Increased MCV(>t00F/U 13 (35) EBood Cnem«lry increased ALT>25QU/L) 4 (11) Increased AST (>250 UA) 5 (14) Increased GGT (>450 UA| 4 (11 increased total btkrubm (>2 5 mg/dl| 1 (3| Increased aikahne phosphatase (-2- ULIM) 19 (51) Increased amylase | >2« ULN) 6 (16) ADVERSE KfilTIIOM: A**' The most freauenty reported adverse ev S rented !0 VIRAMUNE* ihetapywi Mteek ipmnml ttattpatam ttm rfrtM YWAMUME- mmt ke *»m8iih >* palwtt levavlefkM I wm*J**mim), mi-quill k-ce-r tfMkMl vyeeflMM sack as tenf. HMvMb, otI lesiets. op^mcMIs. nMMn, MHttt or |Mfll aches w lateral iMim. [sm nEECMmoM. itiirHta a* i l4-«atj lea* a MtrWi ef M Mtftt* |4 ikEutayt-f ■ pttttlrk iaftef*i|. tMdl Ml Mm Mm M rln lttfr.MW^-Jrafl.lraikiiikiifVill^tMli-4^ Mi mttwi < See DOSAGE AM lOMMSTRJirnN) Sever, w m Wrmi—i NkakMidukj. wniin fate! WmeeeM MtaMB IhmiEWM ilnklm. m m »4kte-« MiwtliiraMieMtt. piliikU RrW tWuMMimn M—, m mHiptlHi). *» nam M pMMet, Ira* ■*» WAWF Stmt Owcan Mtjn m t» Itrtt tew -weta t. Urtvjw Mtnmwm i.cie-jiMiI *, im». WWIIUNE- KiHiilliii OmU It mm\ttyM m patttwtt apthmtim ..iIwMe er mm AIT ■ AIT akeer oaMfm MM M tlMtl M EJWJme nten «nVUJIUMP ShevU M piittawMhi kcHllMII it IHwt MaOM ^E»teMlM»!.IKtrMWIMMMM»NM«.NMll I ill I. MMtiMN MtM|Ml tart M ewMki M mAMJNr UllflM. (See PRECAUTIONS MoflWPM Mr <WMtt: ADVERSE REACTIONS. The r,-*y dawa* touctly of VIRAMUNE* is rash .with VIRAMUNE" annbutabte rash occurring m 11\ ot patents -—- reganens m Phase ll/lll controlled stixkes Thirty seven percent ol tjatents Ireated with VIRAMUNE" * compared with 20% of patents treated n control groups of ethetZDV.<Mi or ZDV alone I Tat* 2| Severe or irle rweaiening rash occurred «i 16% o( VIRAMUNE" treated HMnts combated with 1 2% of patients treated «i me control groups Hashes are usuaky mild to moderate. macutopapuiar erythematous cutaneous eruptions with or without pruritus. located on Itie Hunk, lace and extremities T^e rouotrty ot severe rashes occurred withm the firsl 28 days ot treat nent 25*. ot the patients -with severe rashes required hospitalization and one patieM leouired surgical intervention AN pahents recovered Overall. T\ of patents thscontimied VIRAMUNE* due to rash aNe 2 Percemage ot Patents with Rashes n ■dun Controeed Trials ACTG241" EH 1037 811011 COMBINED 0ATA NVP.2DV rta ZDV*dd KVP.ZDV ZDV NVPtZDV ZDV NVP CUNTFOl n 197 201 30 30 25 24 252 255 Rash events olal Grades at* atcausany 39.6% 239% 26 7\ 67% 32.0% 42% 37 3\ 200% in*** ' 'isn events; all caosaMy 8.1% 1.5% 33% 0% 8.0% 0% 76% '» The Ovmn at dwiwl DemM from ant«-lrovwal theraoy rnay be h antntrnwal therapy may contnue n develop onnfluntsOc inlections ana uotei corr therefore should reman under close cimcai obsavanon by physicians expenenctd m the tteatment ot patients with asfOC-M HW deeases I ot an antiretroviral regimen, the complete product information for each ther jf one 200 mg tablet darfy tor the first it toys fnloww) by one 200 mg tablet twice datty 11 Tna. ACTG 241 was designed to report Grade 3/4 (severe m ine-thr-aleiwg] events eicept tw several pre-specihed events including rash lot when an grades are reported Table 3 lists treat mem-related cHnca adverse events rhat occurred m itftents receiving VIRAMUNE* m ACTG 241 and ^ Trials Bl 1037 and Bl 1011 induction ol CYP3A By neyirapm* mav resull m lower p r, admneaerefl drugs that ant nrtmsMsiv -Tiesaboiia-J By CVP3A fSe« a*iiCAL F*HAH*MC0irjGV> Thus 1 a as been staUUM an a Aeag^ regetten to «: VIRAMUNE' and nefoconsvole should not be and neiocwwoie itsuted <i a sqnrkant reductinn m kMcccnanle pttsma caricefflrihons (See CLINICAL PHARMACOLOGY Drug interactions, uVit CesncealMts: There are no clrad ijan >tevitaDiriemayOecreawpw»rrucana^^ these drugs should not De jdm-iwered contoniitamty with VIRAMUNE' anrltaM » prtjt«|it M«> ttw pl^^ fte test 6 weeks ot «iabon ol therapy Pttnts should be Etsttucted that 4 any rash cosirs dunrg ln« tvw>wee* lead-ei pencd the VIRAMUNE' dose should not M escalated unW the-ash tsoiws Any pat-en: eiperenong seve-e ?sn « a rash accompanied by const-tuhonai symptoms such as lever onsieting oral lesnns. conmndivitis. sMtkng muscle ot (Ml aches, ot general matae should n-imedatety discontinue medcahon and consul a physcati Palierfc should Wir^tucted that atwrmalirvw recjafios have been reported w* V»UU*JME- Lr*t luncbon tests should be mon«ored es|»c^ during ihe hrg sii months of Hwapy. VlfvVMJNE^ adrninrstrahon should be 'rtet■upted in pahents e*petetticmg moderakt ot severe kver luncbsn lest ^wiiiawti. uM luer function tests return to tuselme values. VIRAMUNE- should be oemunetitfy avs contimied i kver function atttormaltnes reciu upon -eadminfif ration Pahents should be -Tstrucied to consult their physicians imnvsdufely should symptoms ot hepatite occut Oral contraceptrws and other tiomwnal methods ot bwth control should not be used as a method of cortiwpbon m women tatong ViiuVtwUNE" (See PRECAUTIONS drug Itmnaions) i^ierrrs shaiid M irilormed that WRAM^ to others tntough se.ua! contact * wood contaminalion Ttxior^letmettectsotVtluuVILWE- afe.niuTownatttvshme rsrrtataKlvHt^lEMCitin pa^ Trearmerrt with VIRAMUNE" has not Been shown to iedu« W .nooenct o< ews snoun t» at>nMd to narian urioto «w take VIRAMUNE' every day as prescribed Patients should not alter tie dose without Tawe 3 Cottiparattve Incidence ol SHecied Drug Heiaied Events m Adult Controlled Ml WTO 241 Tral 811037and BMOIt Grade 3/4 events Al seventies r,V'..'!:vV1.]l ZDV.ddl NVP.ZDV ZDV alone NumOe' ol patients 197 201 55 30 Overal ruotna ot related aoverss everts 31% 23% 42% 33% Rash 8 2 20 3 Fever 3 3 11 3 Nausea 5 4 9 1 Headache 3 3 11 0 Nmimji 2 2 0 0 J.IOornnul pain 1 2 2 0 Ulcerative stomatitis 0 0 4 0 Penpnefalneufuti'li-, 0 2 0 0 Paresthesia 1 0 2 0 Myaloia 1 0 2 1 0 4 0 AMerwiWiei: Table 4 summarizes matted OOo Table 4: Percenaoe ot Adult Patients w lory abnormal*** oecutritg ei Ihne contnsled studw i Matted Laboraioty Abnormalities cy.Ttsucn ■ Hg(<80 grail aWetets ^SOOtJuVrtim1! ---'■'-(<750mlnY) ALI(>250uVL) AST 1.250 U/Lj GGT|>450IjVI) tnttfthlUbin(>25ingWL) tt if rMlttjc Long-term canprngenaty studies ot :urwit, m progiess m genet.: toiiccwjgy assays nevrac.ne shrowed no ftioerw ot mutagen* ot daaogenc actwfy >■ a ladEry of ei »M and n nw attsays intsyjoVng -; cow), mammalian ceJ gent mutation assays iCHO.HCPRTt cywgenepc assays using a Chants* hamstet ovary eel IptMM r.f.ifhes d on AUC appron wtinvendtd especialty duting Ihe tirsf so m. iruvhit .uq ^vsfernff eiposure l*N8lVMIUF Wiptwt|. -"egnancv Categor, C No DOservaWe leiatooemcity was detected m leproductive tf 50% Ikgner based on AUC than that seen at the recommended human ckneal dose tat no^rjbswivaoit eltect level dosages in tats and rabbits produced system*; — '"% i-ghw. test«awely. than ttov and I*?'! cnmroiuid-.; .^^ riprf, Wtmatic elevations in GGT levels are more frequent in VIRAMUNE* recipients than in controls Because Ckmcal Nshasoe^'wrtedinVlRAMuMMieaM « ol VIIUMUW' treatment , See WARNINGS, 1Sr«aWI0WRAMlJHE',npedalricpa " ■ ■ tM HI mm comr.on\ of " IMMH 'u-i iHit beeih esLih!,s"ed n antidote 'i- VIRAMUNE' ovetdosage Cases ol VlFtAMUNE* ovetdose at doses ■arginij fiom 800 to l8tM mtj per tliy ttir up to 15 ittys Maw been reporreej Pahents have eipenenced tNents TOucwig — *ihgu*. ttvtt headache msomna. nuM " is supsTjefl loiio" ng MeoM MM M Pi HMRi MM EklikjMJU In >MT% IMtenr PrekRvatvy irjsufs ffl^ wonten wt« were adtniHWed a swtte or* u^ intkate that nivirapfie readrly cmsses the placenta and is found m breast mtk Consistent with the i»a-T*T>*nilaon by the US Public MeaBh Service Centers tot Disease Control and F^everihcn that HTV-intededitKithefsr^ iTtarts to M>d ttsfraii ptMatt Peetewx bkc Safety wk assessed m mat 81852 m wheh pahenls were Mowed lor a mean uuraMn of 33 9 -norths ■'*ioe b"3-horrnsfoS3'fears rcluoviig wcj-ierm'on^-up ir?9oi these palieirtsji'rai Bl 992i The most TequemN reticriedathwsee««ksi*«akdn wtththe erceotion ot granutocytcmna when was more commoiiiy oKer^ in chrttten Serious adverse events were assessed ■ ACTG ?45 a double Wnd placebo controlled trial rfWfi>J*iNE- |n = 305) m wheh ptaUnc patents received MnWabon treatment ■* vrtWIU*' m the; tie! two pahents were reported ID ewerenct SW-WVJilhnson svn- liYtjnytafSieMfts-JDlmorVt^ Cases of aiietgic reaction irciuthng one case ot anat>hyta«. «««a^-evortefl Tie eval^ RX-2267CABW (4/991 f III I Boehringerlngelheiin MlHiy Roxane Laboratories GLSEN's Brenda Barron says only two school systems—in California and Utah—have not allowed chapters of gay-straight alliances. harassment, that they can fight back. I'm not afraid, no matter what may happen. I'm never going back into the closet. Never." A rough road to take Pfeiffer's transformation to gay activist didn't occur without personal angst and pain. Although he suspected he was gay for many years, it wasn't until he was a teenager that he came to grips with the reality. During middle school years—sixth through eighth grades—he endured perpetual taunting and teasing. "I was preppy in those days," he says. "I sensed I was different, and at that age 'different' is bad. The worst thing you could assign to yourself was that you're gay. "I was called 'fag' daily, teased, and picked on. Why? Because I was quiet and kept to myself, and I didn't like girls." Pfeiffer said his depression deepened. As he moved into high school, rumors that he was gay persisted "and I was making a real effort to hide it." When his mother "had the big sex talk with me, I told her I'd never have sex with a woman, so she knew something was up." Sensing her son's growing despair, his mother got him into therapy. By ninth grade, Pfeiffer said, he had had enough. "1 here were a lot of things going on in the news, and 1 was beginning to mourn the fact that I never had a childhood because of the way other students treated me. "One day, my mom and I were in Wal-Mart—I could show you the exact spot—and she asked me what was wrong, why 1 was so quiet. So 1 jusl blurted it out. ... She said it wasn't a complete surprise. I think she talked to my aunt, who's really cool .. I know it wasn't easy for her, but my mother made if very clear she loved me no matter what." It was his mother who found a gay youth group at the Baton Rouge lambda Center, and who continues to provide constant support. "My father, well, that's a different story," Pfeiffer says quietly. I lis father believes homosexuality is wrong "so we don't talk about it much." T'amily counseling has eased some of the stress, he adds, "but it's still very hard." Rebel with a cause Pfeiffer began networking through Umbda, the Gay, Lesbian and Straight Education Network, and the Internet, and his transformation from timid closet-case to out-and- proud gay activist continues. "Being gay is not about sexual behavior, you know," he says. "Why characterize someone thai way? People want to reduce il to sex, but that's unfair. ... Everyone assumes you're heterosexual, but how do you know that? How do you know you're gay? You just know by the way you read to people. Bui we receive signals and have internalized messages society has sent us: Don't buck the system; don't
File Name uhlib_31485329_n1003_012.jpg